HOSPITAL DISCHARGE TREND WITH DIAGNOSIS OF SALPINGITIS AND/OR OOPHORITIS BETWEEN THE YEARS 2017 AND 2020 IN CHILE: DESCRIPTIVE ANALYSIS
Keywords:
Hospitalization, Inflammatory Pelvic Disease, Salpingitis, Oophoritis, ChileAbstract
Introduction: Pelvic inflammatory disease (PID) is an inflammatory disorder of the female reproductive tract, which can cause salpingitis and oophoritis. In England it was estimated that in 2016, 33.6% of women between the ages of 35-44 had at least one episode of PID, and of these, 16.1% had salpingitis. The objective of this research is to describe the frequency of hospital discharge due to salpingitis/oophoritis in the period 2017-2020 in Chile. Materials and methods: Descriptive observational study, which included women with a hospital discharge diagnosis of salpingitis/oophoritis in the period 2017-2020 in Chile (n=6.382), data from the database of the health information and statistics department From Chile. Hospital discharge rates were calculated using data from the 2017 Chilean census. No ethics committee was required. Results: 64.6% (4.121) corresponded to women between the ages of 20-44, 33.3% (2.123) between the ages of 45-64 and 2.2% (138) between the ages of 15-19. 16% correspond to acute salpingitis/oophoritis, 17.3% to chronic cases, and 66.7% were not specified. The hospital discharge rate for salpingitis/oophoritis decreased between the years 2017-2020, from 27.6 to 19.4 per 100,000 women. Discussion: The cases studied are concentrated between the ages of 20-44, that is, women of reproductive age and sexually active. The decrease in the cases studied until 2020 is multifactorial, highlighting the confinement as a measure to stop the COVID-19 pandemic. Most of the cases were not specified, possibly due to the diagnostic difficulty given the nonspecific symptoms of these pathologies. More research is needed to improve timely diagnosis.
References
Wright Díaz RÁ. Factores de riesgo prevalentes en enfermedad pélvica inflamatoria. Universidad Veracruzana. Región Veracruz. Facultad de Medicina; 2018.
Ortiz MC, Rivera FS, Medina CD. Actualización sobre enfermedad pélvica inflamatoria. Rev Clin Esc Med. 2020;10(3):19-25.
Lozada Martinez ID, Ospina Pérez C, Ospina Pérez R, Bolaño Romero MP. Enfermedad pélvica inflamatoria como diagnóstico diferencial del dolor abdominal quirúrgico. Cienc innov salud [Internet]. 2020; Disponible en: http://dx.doi.org/10.17081/innosa.100.
Brunham RC, Gottlieb SL, Paavonen J. Pelvic inflammatory disease. N Engl J Med. 2015;372(21):2039–48.
Ross J, Guaschino S, Cusini M, Jensen J. 2017 European guideline for the management of pelvic inflammatory disease. Int J STD AIDS. 2018;29(2):108–14.
Revzin MV, Mathur M, Dave HB, Macer ML, Spektor M. Pelvic inflammatory disease: Multimodality imaging approach with clinical-pathologic correlation. Radiographics. 2016;36(5):1579–96.
Price MJ, Ades AE, Welton NJ, Simms I, Horner PJ. Pelvic inflammatory disease and salpingitis: incidence of primary and repeat episodes in England. Epidemiol Infect. 2017;145(1):208–15.
Lemly D, Gupta N. Sexually transmitted infections part 2: Discharge syndromes and pelvic inflammatory disease. Pediatr Rev. 2020;41(10):522–37.
Price MJ, Ades AE, Welton NJ, Simms I, Horner PJ. Pelvic inflammatory disease and salpingitis: incidence of primary and repeat episodes in England. Epidemiol Infect. 2017;145(1):208–15.
Paulina VN, Mieville PSB, Camus FA. Prevalencia de la infección de Chlamydia trachomatis y su potencial impacto perinatal en pacientes chilenas. Rev Chilena Infectol [Internet]. 2021 [citado el 21 de agosto de 2021];38(4). Disponible en: https://revinf.cl/index.php/revinf/article/view/998/655.
Cannoni G, Ribbeck D, Hernández O, Casacuberta MJ. Actualización de la infección por Chlamydia trachomatis en mujeres. Rev médica Clín Las Condes. 2021;32(2):231–9.
Detailed STD facts - pelvic Inflammatory Disease - CDC fact sheet [Internet]. Cdc.gov. 2021 [citado el 29 de agosto de 2021]. Disponible en: https://www.cdc.gov/std/pid/stdfact-pid-detailed.htm.
La OMS caracteriza a COVID-19 como una pandemia [Internet]. Paho.org. [citado el 29 de agosto de 2021]. Disponible en: https://www.paho.org/es/noticias/11-3-2020-oms-caracteriza-covid-19-como-pandemia.
Pinto CN, Niles JK, Kaufman HW, Marlowe EM, Alagia DP, Chi G, et al. Impact of the COVID-19 pandemic on chlamydia and gonorrhea screening in the U.s. Am J Prev Med. 2021;61(3):386–93.
Cito G, Micelli E, Cocci A, Polloni G, Russo GI, Coccia ME, et al. The impact of the COVID-19 quarantine on sexual life in Italy. Urology. 2021;147:37–42.
Siches I, Vega J, Chomalí M, Yarza B, Estay R, Goyenechea M, Jiménez P, Aliaga A, Águila F, Troncoso J, Pacheco J. El impacto de COVID-19 en el sistema de salud y propuestas para la reactivación [Internet]. 2020 [citado el 30 de agosto de 2021]. Disponible en: http://www.colegiomedico.cl/wp-content/uploads/2020/08/reactivacion-sanitaria.pdf.
Dell’Utri C, Manzoni E, Cipriani S, Spizzico C, Dell’Acqua A, Barbara G, et al. Effects of SARS Cov-2 epidemic on the obstetrical and gynecological emergency service accesses. What happened and what shall we expect now? Eur J Obstet Gynecol Reprod Biol. 2020;254:64–8.
Daykan Y, Tamir Yaniv R, Yagur Y, Pomeranz M, Arbib N, Klein Z, et al. Did COVID-19 quarantine redirect habitual patient visits in the gynecology emergency room? J Gynecol Obstet Hum Reprod. 2021;50(10):102199.
Baquedano Mainar, L., Lamarca Ballestero, M., Puig Ferrer, F. y Ruiz Conde, MA (2014). Enfermedad inflamatoria pélvica: un reto en el diagnóstico y tratamiento precoz. Revista Chilena de Obstetricia y Ginecología, 79 (2), 115–120.
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2023 Johana, María Fernanda , Tomás, Noelia, Dr. Pedro Morales
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
